A phase II study of efficacy as well as safety of Leukocyte cell therapy in patients with moderate knee osteoarthritis
Latest Information Update: 14 Sep 2023
At a glance
- Drugs Leukocyte-cell-therapy-Enlivex-Therapeutics (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
Most Recent Events
- 14 Sep 2023 New trial record
- 11 Sep 2023 According to an Enlivex media release, company will initiate this trial in early 2024 and topline data readout expected by the end of Q2 2025.